As per the recent report by IMARC Group, titled ‘Proteomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032,’ offers a comprehensive analysis of the proteomics market statistics. The report also includes competitor and regional analysis, along with a breakdown of segments within the industry.
The global proteomics market size reached US$ 36.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 126.2 Billion by 2032, exhibiting a growth rate (CAGR) of 14.4% during 2024-2032.
Proteomics Market Overview:
Proteomics is the large-scale study of proteins, which are vital parts of living organisms, with many functions. This field utilizes proteomics technologies and methodologies to identify, quantify, and study protein activities and structures. It significantly aids in understanding diseases and discovering new drug targets for complex conditions such as cancer and neurodegenerative disorders. Proteomics involves techniques like mass spectrometry and protein microarrays, which allow for the detailed analysis of protein interactions and the expression levels of proteins in different types of cells and tissues. Advantages of employing proteomics include the ability to generate comprehensive data about protein production and regulation within specific cellular processes, which is crucial for clinical research and pharmaceutical development.
Get Sample Copy of Report at – https://www.imarcgroup.com/proteomics-market/requestsample
Global Proteomics Market Trends:
The global proteomics market is primarily driven by the increasing prevalence of chronic diseases such as cancer, which necessitates advanced diagnostic and therapeutic technologies. In line with this, the rising focus on personalized medicine is also providing an impetus to the market. Moreover, the significant increase in biopharmaceutical research and development is acting as a crucial growth-inducing factor. In addition to this, the expansion of proteomics studies in academic and research institutions, due to their potential to improve understanding of disease mechanisms, is resulting in higher demand for proteomics solutions.
Furthermore, the growing investment in healthcare infrastructure across developing nations is creating lucrative opportunities in the market. Also, the enhancement of analytical techniques and tools in proteomics is positively influencing the market’s growth. The market benefits further from substantial funding for proteomics projects by governments and private organizations worldwide. Apart from this, the integration of artificial intelligence and machine learning technologies is propelling the market by improving the efficiency and accuracy of proteomic analysis. Some of the other factors contributing to the market growth include the increasing collaboration between academic institutions and pharmaceutical companies, the widespread adoption of advanced technologies in drug discovery, and extensive clinical research initiatives.
Key Players in the Proteomics Industry:
The competitive landscape of the industry has also been examined along with the profiles of the key players being:
Agilent Technologies Inc.
Bio-RAD Laboratories Inc.
Bruker Corporation
Creative Proteomics
Danaher Corporation
GE Healthcare Inc.
Horiba Ltd.
Luminex Corporation
Merck Group
Perkinelmer Inc.
Promega Corporation
Thermo Fisher Scientific Inc.
Waters Corporation, etc.
Market Segmentation:
Breakup by Analysis Type:
Structural Proteomics
Functional Proteomics
Protein Expression Proteomics
Breakup by Component Type:
Core Proteomics Services
Bioinformatics Software and Related Services
Breakup by Technology:
Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Surface Plasmon Resonance
Others
Breakup by Application:
Protein Expression Profiling
Proteome Mining
Post-translational Modifications
Breakup by End-User:
Clinical Diagnostic Laboratories
Research Organizations (Drug Discovery)
Others
Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the Report:
Market Performance
Market Outlook
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Competitive Structure
Profiles of Key Players
Why Choose IMARC Research Report:
Strong Market Research Expertise
Targeted Marketing Strategies
Innovative Solutions
Comprehensive Analysis
Accuracy and Reliability
Provides Insightful Forecasts
Available Customization Options
Strong Customer Service
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Comments